BioStock: Show of resilience from BiBBInstruments during Q2

Despite the challenges driven by the pandemic and some production issues during the first half of 2021, Swedish medtech BiBBInstruments has managed to keep to the scheduled clinical timelines for evaluating the world’s first CE-marked electric biopsy instrument - EndoDrill Model X. BioStock reached out to CEO Fredrik Lindblad for a comment.

Read the full interview with Fredrik Lindblad at biostock.se:

https://www.biostock.se/en/2021/08/show-of-resilience-from-bibbinstruments-during-q2/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se